
Neurologist

No OPD information available
Multiple Sclerosis (MS)
Hashimoto Thyroiditis
Relapsing Multiple Sclerosis (RMS)
Alternating Hemiplegia of Childhood
Anti-NMDA Receptor Encephalitis
Bone Marrow Transplant
CACH Syndrome
Chronic Inflammatory Demyelinating Polyneuropathy
Chronic Polyradiculoneuritis
Encephalitis
Epilepsy
Facial Paralysis
Hemiplegia
Leukocytosis
Menopause
Myelitis
Neuromyelitis Optica
Optic Neuritis
Serum Sickness
Transverse Myelitis
Richard L. Macdonell is a male healthcare provider who helps people with different medical conditions like Multiple Sclerosis, Thyroiditis, Encephalitis, Epilepsy, and more. He is skilled in treating these conditions and has experience in Bone Marrow Transplant and other specialized areas. 
Richard L. Macdonell communicates well with his patients, making them feel comfortable and confident in his care. Patients trust him because he listens to their concerns and explains things clearly. 
To stay updated with the latest medical knowledge, Richard L. Macdonell reads research papers and attends conferences. This helps him provide the best possible care to his patients. 
Richard L. Macdonell works closely with other medical professionals, collaborating to ensure patients receive comprehensive care. He values teamwork and respects his colleagues' expertise.
Through his work, Richard L. Macdonell has positively impacted many patients' lives. His dedication to providing quality care and his expertise in treating complex conditions have helped improve the health and well-being of those he serves.
One of Richard L. Macdonell's notable publications is "Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis," published in JAMA Neurology. This research contributes to the understanding of Multiple Sclerosis progression.
He has also been involved in clinical trials, such as the study on the effect of MD1003 in Progressive Multiple Sclerosis. Even though the trial was terminated, the research conducted contributes to advancing treatment options for patients with Progressive MS.
Overall, Richard L. Macdonell's dedication to his patients, commitment to staying informed, and contributions to medical research make him a respected and trusted healthcare provider in his field.
Enrollment Status: Terminated
Published: November 23, 2020
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
